{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/77687"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/77687","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Liposome Encapsulated Manganese Chloride as a Liver Specific Contrast Agent for Magnetic Resonance Imaging","abstract":"A study was undertaken to examine the possibility of using a liposome encapsulated paramagnetic ion (Mn$\\sp{2+}$) as a contrast agent for magnetic resonance imaging (MRI) of the liver. Previous work with liposomes had shown that liposomes were concentrated in the liver after intravenous injection. Uptake of the vesicles into tumors was shown to be negligible. This suggested the possibility that the differences in uptake of the Mn$\\sp{2+}$ in liposomes between liver and tumor might provide a means of highlighting tumors using MRI. Electron spin resonance (ESR) and proton nuclear magnetic resonance (NMR) relaxation were used in experiments to study the blood clearance, liver uptake and vesicle break down. The results showed that the Mn$\\sp{2+}$ must be released from the vesicle and transferred to some extent to hepatocytes in order to bring about effective relaxation enhancement in liver tissue. After study of several different liposome preparations, it was found that vesicles composed of phosphatidylcholine, phosphatidylserine and cholesterol brought about the most rapid reduction in liver relaxation times. This vesicle preparation was injected intravenously into Fisher 344 rats with implanted liver tumors. The vesicles caused a marked reduction in the relaxation times of liver tissue, but little change in the relaxation times of the tumor. Magnetic resonance images obtained at 0.5 Tesla showed a large increase in the signal intensity in the liver and little change in the tumor. The results of this investigation showed the effectiveness of encapsulated Mn$\\sp{2+}$ as an MRI contrast agent for liver metastases.","abstract_html":"A study was undertaken to examine the possibility of using a liposome encapsulated paramagnetic ion (Mn$\\sp{2+}$) as a contrast agent for magnetic resonance imaging (MRI) of the liver. Previous work with liposomes had shown that liposomes were concentrated in the liver after intravenous injection. Uptake of the vesicles into tumors was shown to be negligible. This suggested the possibility that the differences in uptake of the Mn$\\sp{2+}$ in liposomes between liver and tumor might provide a means of highlighting tumors using MRI. Electron spin resonance (ESR) and proton nuclear magnetic resonance (NMR) relaxation were used in experiments to study the blood clearance, liver uptake and vesicle break down. The results showed that the Mn$\\sp{2+}$ must be released from the vesicle and transferred to some extent to hepatocytes in order to bring about effective relaxation enhancement in liver tissue. After study of several different liposome preparations, it was found that vesicles composed of phosphatidylcholine, phosphatidylserine and cholesterol brought about the most rapid reduction in liver relaxation times. This vesicle preparation was injected intravenously into Fisher 344 rats with implanted liver tumors. The vesicles caused a marked reduction in the relaxation times of liver tissue, but little change in the relaxation times of the tumor. Magnetic resonance images obtained at 0.5 Tesla showed a large increase in the signal intensity in the liver and little change in the tumor. The results of this investigation showed the effectiveness of encapsulated Mn$\\sp{2+}$ as an MRI contrast agent for liver metastases.","abstract_has_math":true,"creators":["Niesman, Michael Ross"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["Magin, Richard"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-05-14T15:21:27Z","date_published":"2015-05-14T15:21:27Z","updated_at":"2026-07-22T22:26:11Z","subjects":["Biology, General","Chemistry, Pharmaceutical"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(UMI)AAI8823215"],"render_values":[{"text":"(UMI)AAI8823215","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/77687","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Magin, Richard"]},{"key":"dc:creator","label":"Author","values":["Niesman, Michael Ross"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-05-14T15:21:27Z","10000-01-01","1988"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology, General","Chemistry, Pharmaceutical"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/77687","(UMI)AAI8823215"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["A study was undertaken to examine the possibility of using a liposome encapsulated paramagnetic ion (Mn$\\sp{2+}$) as a contrast agent for magnetic resonance imaging (MRI) of the liver. Previous work with liposomes had shown that liposomes were concentrated in the liver after intravenous injection. Uptake of the vesicles into tumors was shown to be negligible. This suggested the possibility that the differences in uptake of the Mn$\\sp{2+}$ in liposomes between liver and tumor might provide a means of highlighting tumors using MRI. Electron spin resonance (ESR) and proton nuclear magnetic resonance (NMR) relaxation were used in experiments to study the blood clearance, liver uptake and vesicle break down. The results showed that the Mn$\\sp{2+}$ must be released from the vesicle and transferred to some extent to hepatocytes in order to bring about effective relaxation enhancement in liver tissue. After study of several different liposome preparations, it was found that vesicles composed of phosphatidylcholine, phosphatidylserine and cholesterol brought about the most rapid reduction in liver relaxation times. This vesicle preparation was injected intravenously into Fisher 344 rats with implanted liver tumors. The vesicles caused a marked reduction in the relaxation times of liver tissue, but little change in the relaxation times of the tumor. Magnetic resonance images obtained at 0.5 Tesla showed a large increase in the signal intensity in the liver and little change in the tumor. The results of this investigation showed the effectiveness of encapsulated Mn$\\sp{2+}$ as an MRI contrast agent for liver metastases.","Made available in DSpace on 2015-05-14T15:21:27Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 8823215.PDF: 5107626 bytes, checksum: 2bad89d7bd5e29f1788fe0e254ea881b (MD5) Previous issue date: 1988","Embargo set by: Seth Robbins for item 78897 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","137 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1988."]},{"key":"dc:title","label":"Title","values":["Liposome Encapsulated Manganese Chloride as a Liver Specific Contrast Agent for Magnetic Resonance Imaging"]}]}],"canonical_facts":{"dc:contributor":["Magin, Richard"],"dc:creator":["Niesman, Michael Ross"],"dc:date":["2015-05-14T15:21:27Z","10000-01-01","1988"],"dc:description":["A study was undertaken to examine the possibility of using a liposome encapsulated paramagnetic ion (Mn$\\sp{2+}$) as a contrast agent for magnetic resonance imaging (MRI) of the liver. Previous work with liposomes had shown that liposomes were concentrated in the liver after intravenous injection. Uptake of the vesicles into tumors was shown to be negligible. This suggested the possibility that the differences in uptake of the Mn$\\sp{2+}$ in liposomes between liver and tumor might provide a means of highlighting tumors using MRI. Electron spin resonance (ESR) and proton nuclear magnetic resonance (NMR) relaxation were used in experiments to study the blood clearance, liver uptake and vesicle break down. The results showed that the Mn$\\sp{2+}$ must be released from the vesicle and transferred to some extent to hepatocytes in order to bring about effective relaxation enhancement in liver tissue. After study of several different liposome preparations, it was found that vesicles composed of phosphatidylcholine, phosphatidylserine and cholesterol brought about the most rapid reduction in liver relaxation times. This vesicle preparation was injected intravenously into Fisher 344 rats with implanted liver tumors. The vesicles caused a marked reduction in the relaxation times of liver tissue, but little change in the relaxation times of the tumor. Magnetic resonance images obtained at 0.5 Tesla showed a large increase in the signal intensity in the liver and little change in the tumor. The results of this investigation showed the effectiveness of encapsulated Mn$\\sp{2+}$ as an MRI contrast agent for liver metastases.","Made available in DSpace on 2015-05-14T15:21:27Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 8823215.PDF: 5107626 bytes, checksum: 2bad89d7bd5e29f1788fe0e254ea881b (MD5) Previous issue date: 1988","Embargo set by: Seth Robbins for item 78897 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","137 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 1988."],"dc:identifier":["http://hdl.handle.net/2142/77687","(UMI)AAI8823215"],"dc:language":["eng"],"dc:subject":["Biology, General","Chemistry, Pharmaceutical"],"dc:title":["Liposome Encapsulated Manganese Chloride as a Liver Specific Contrast Agent for Magnetic Resonance Imaging"],"dc:type":["text"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:11Z"}